pyrazolanthrone has been researched along with carbostyril in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernández-Galilea, M; Martinez, JA; Moreno-Aliaga, MJ; Pérez-Matute, P; Prieto-Hontoria, PL | 1 |
| Breault, DT; Carlone, DL; de Sousa Casal, J; Dubois, S; Hafner, S; Karp, JM; Mannam, P; Ordovas-Montanes, J; Qi, W; Shah, MS; Stas, E; Syverson, EP; Yin, X; Zeve, D | 1 |
2 other study(ies) available for pyrazolanthrone and carbostyril
| Article | Year |
|---|---|
Effects of lipoic acid on lipolysis in 3T3-L1 adipocytes.
Topics: 3T3-L1 Cells; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Anthracenes; Carrier Proteins; Chromones; Isoquinolines; JNK Mitogen-Activated Protein Kinases; Lipase; Lipolysis; Mice; Morpholines; Perilipin-1; Phosphoproteins; Phosphorylation; Quinolones; Ribonucleotides; Sterol Esterase; Sulfonamides; Thioctic Acid | 2012 |
Robust differentiation of human enteroendocrine cells from intestinal stem cells.
Topics: Anthracenes; Cell Differentiation; Chromogranin A; Endocannabinoids; Enteroendocrine Cells; Glucagon-Like Peptide 1; Humans; Intestinal Mucosa; Peptide YY; Quinolones; Rimonabant; Signal Transduction; Somatostatin; Stem Cells; Transcription Factors | 2022 |